Michel Morlot

477 total citations
8 papers, 204 citations indexed

About

Michel Morlot is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Michel Morlot has authored 8 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Michel Morlot's work include Sexual Differentiation and Disorders (3 papers), Hormonal Regulation and Hypertension (3 papers) and Hormonal and reproductive studies (2 papers). Michel Morlot is often cited by papers focused on Sexual Differentiation and Disorders (3 papers), Hormonal Regulation and Hypertension (3 papers) and Hormonal and reproductive studies (2 papers). Michel Morlot collaborates with scholars based in Germany, Italy and Slovakia. Michel Morlot's co-authors include Wolfgang G. Sippell, Carl‐Joachim Partsch, Nils Krone, Felix G. Riepe, Paul‐Martin Holterhus, Olaf Hiort, Michael Ludwig, Christine Marschke, Michael Peter and Gerhard Binder and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Human Mutation and Hormone Research in Paediatrics.

In The Last Decade

Michel Morlot

8 papers receiving 202 citations

Peers

Michel Morlot
Vaitsa Tziaferi United Kingdom
Priscila Gagliardi United States
Ferdy S. van Geest Netherlands
Iris A. Horst United States
Federica Buonocore United Kingdom
Werner Lenz Germany
Primus-E. Mullis Switzerland
Michel Morlot
Citations per year, relative to Michel Morlot Michel Morlot (= 1×) peers Paola Malatesta

Countries citing papers authored by Michel Morlot

Since Specialization
Citations

This map shows the geographic impact of Michel Morlot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Morlot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Morlot more than expected).

Fields of papers citing papers by Michel Morlot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Morlot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Morlot. The network helps show where Michel Morlot may publish in the future.

Co-authorship network of co-authors of Michel Morlot

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Morlot. A scholar is included among the top collaborators of Michel Morlot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Morlot. Michel Morlot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Golas, Monika M., Bernd Auber, Tim Ripperger, et al.. (2019). Looking for the hidden mutation: Bannayan–Riley–Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A. American Journal of Medical Genetics Part A. 179(7). 1383–1389. 9 indexed citations
2.
Werner, Ralf, Paul‐Martin Holterhus, Gerhard Binder, et al.. (2006). The A645D Mutation in the Hinge Region of the Human Androgen Receptor (AR) Gene Modulates AR Activity, Depending on the Context of the Polymorphic Glutamine and Glycine Repeats. The Journal of Clinical Endocrinology & Metabolism. 91(9). 3515–3520. 38 indexed citations
3.
Krone, Nils, Felix G. Riepe, Helmuth‐Günther Dörr, et al.. (2005). Thirteen novel mutations in theNR0B1(DAX1) gene as cause of adrenal hypoplasia congenita. Human Mutation. 25(5). 502–502. 16 indexed citations
4.
Riepe, Felix G., Nils Krone, Michel Morlot, et al.. (2004). Autosomal-Dominant Pseudohypoaldosteronism Type 1 in a Turkish Family Is Associated with a Novel Nonsense Mutation in the Human Mineralocorticoid Receptor Gene. The Journal of Clinical Endocrinology & Metabolism. 89(5). 2150–2152. 23 indexed citations
5.
Riepe, Felix G., Nils Krone, Michel Morlot, et al.. (2003). Identification of a Novel Mutation in the Human Mineralocorticoid Receptor Gene in a German Family with Autosomal-Dominant Pseudohypoaldosteronism Type 1: Further Evidence for Marked Interindividual Clinical Heterogeneity. The Journal of Clinical Endocrinology & Metabolism. 88(4). 1683–1686. 28 indexed citations
6.
Holterhus, Paul‐Martin, et al.. (2000). Clinical, Endocrine, and Molecular Genetic Findings in Patients with 17β-Hydroxysteroid Dehydrogenase Deficiency. Hormone Research in Paediatrics. 53(1). 26–31. 30 indexed citations
7.
Xie, Jun, Silvana Pannain, Joachim Pohlenz, et al.. (1997). Resistance to Thyrotropin (TSH) in Three Families Is not Associated with Mutations in the TSH Receptor or TSH1. The Journal of Clinical Endocrinology & Metabolism. 82(12). 3933–3940. 46 indexed citations
8.
Miller, Konstantin, et al.. (1997). Mosaicism in trisomy 8: phenotype differences according to tissular repartition of normal and trisomic clones.. PubMed. 40(3). 181–4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026